Back to top

earnings-consensus: Archive

Zacks Equity Research

Wall Street Analysts Think AES (AES) Could Surge 34.06%: Read This Before Placing a Bet

The consensus price target hints at a 34.1% upside potential for AES (AES). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

AESPositive Net Change

Zacks Equity Research

How Much Upside is Left in Valneva (VALN)? Wall Street Analysts Think 135.3%

The consensus price target hints at a 135.3% upside potential for Valneva (VALN). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

VALNPositive Net Change

Zacks Equity Research

Target (TGT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Target (TGT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

TGTPositive Net Change

Zacks Equity Research

TJX (TJX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

TJX (TJX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

TJXPositive Net Change

Zacks Equity Research

Analysts Estimate Urban Outfitters (URBN) to Report a Decline in Earnings: What to Look Out for

Urban Outfitters (URBN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

URBNPositive Net Change

Zacks Equity Research

Analysts Estimate Agilent Technologies (A) to Report a Decline in Earnings: What to Look Out for

Agilent (A) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

APositive Net Change

Zacks Equity Research

Macy's (M) Earnings Expected to Grow: Should You Buy?

Macy's (M) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

MPositive Net Change

Zacks Equity Research

Dycom Industries (DY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Dycom Industries (DY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

DYPositive Net Change

Zacks Equity Research

Analysts Estimate GDS Holdings (GDS) to Report a Decline in Earnings: What to Look Out for

GDS Holdings (GDS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GDSPositive Net Change

Zacks Equity Research

Does AngioDynamics (ANGO) Have the Potential to Rally 77.03% as Wall Street Analysts Expect?

The mean of analysts' price targets for AngioDynamics (ANGO) points to a 77% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

ANGOPositive Net Change

Zacks Equity Research

Can Harmony Biosciences (HRMY) Climb 25.05% to Reach the Level Wall Street Analysts Expect?

The mean of analysts' price targets for Harmony Biosciences (HRMY) points to a 25.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

HRMYPositive Net Change

Zacks Equity Research

Wall Street Analysts Believe LifeStance Health (LFST) Could Rally 39.38%: Here's is How to Trade

The mean of analysts' price targets for LifeStance Health (LFST) points to a 39.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

LFSTPositive Net Change

Zacks Equity Research

Wall Street Analysts Think ProAssurance (PRA) Could Surge 27.67%: Read This Before Placing a Bet

The average of price targets set by Wall Street analysts indicates a potential upside of 27.7% in ProAssurance (PRA). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

PRAPositive Net Change

Zacks Equity Research

Wall Street Analysts Believe Synchronoss (SNCR) Could Rally 107.09%: Here's is How to Trade

The mean of analysts' price targets for Synchronoss (SNCR) points to a 107.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

SNCRPositive Net Change

Zacks Equity Research

Wall Street Analysts See a 35.35% Upside in XPEL (XPEL): Can the Stock Really Move This High?

The mean of analysts' price targets for XPEL (XPEL) points to a 35.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

XPELPositive Net Change

Zacks Equity Research

Wall Street Analysts Think Travelzoo (TZOO) Could Surge 37.46%: Read This Before Placing a Bet

The mean of analysts' price targets for Travelzoo (TZOO) points to a 37.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

TZOOPositive Net Change

Zacks Equity Research

Wall Street Analysts Think Biomea Fusion (BMEA) Could Surge 317.86%: Read This Before Placing a Bet

The consensus price target hints at a 317.9% upside potential for Biomea Fusion (BMEA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

BMEAPositive Net Change

Zacks Equity Research

Can Ceva (CEVA) Climb 33.52% to Reach the Level Wall Street Analysts Expect?

The mean of analysts' price targets for Ceva (CEVA) points to a 33.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

CEVAPositive Net Change

Zacks Equity Research

Wall Street Analysts Believe Similarweb (SMWB) Could Rally 36.82%: Here's is How to Trade

The consensus price target hints at a 36.8% upside potential for Similarweb (SMWB). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

SMWBNegative Net Change

Zacks Equity Research

Coty (COTY) Earnings Expected to Grow: Should You Buy?

Coty (COTY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

COTYNegative Net Change ELPositive Net Change

Zacks Equity Research

H World Group (HTHT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

H World Group (HTHT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

HTHTNegative Net Change

Zacks Equity Research

Earnings Preview: Lowe's (LOW) Q2 Earnings Expected to Decline

Lowe's (LOW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

LOWPositive Net Change

Zacks Equity Research

Does CSG Systems (CSGS) Have the Potential to Rally 37.07% as Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 37.1% in CSG Systems (CSGS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

CSGSPositive Net Change

Zacks Equity Research

Wall Street Analysts Believe Sensus Healthcare (SRTS) Could Rally 64.74%: Here's is How to Trade

The consensus price target hints at a 64.7% upside potential for Sensus Healthcare (SRTS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

SRTSNegative Net Change

Zacks Equity Research

Wall Street Analysts Predict a 58.5% Upside in VTEX (VTEX): Here's What You Should Know

The average of price targets set by Wall Street analysts indicates a potential upside of 58.5% in VTEX (VTEX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

VTEXPositive Net Change